OACCUMEDIUM SIGNALFINANCIAL10-K

OACCU completed its initial public offering with partial over-allotment exercise and forfeiture of Class B shares, while current liabilities nearly doubled and stockholder equity deficit expanded.

The IPO process has concluded with underwriters exercising only part of their over-allotment option and forfeiting the remainder, resulting in cancellation of Class B shares as designed. The company remains in early-stage development with negative equity, typical for a SPAC or recently public entity seeking business combinations.

Comparing 2026-03-26 vs 2025-03-27View on EDGAR →
FINANCIAL ANALYSIS

Current liabilities grew substantially from $727K to $1.3M, likely reflecting increased operational and regulatory costs associated with becoming a public company. Stockholders equity remained negative, expanding from -$6.1M to -$6.8M as the company continues to operate at a loss during its early public phase. The financial profile reflects a typical newly public vehicle with ongoing cash consumption and minimal revenue generation.

FINANCIAL STATEMENT CHANGES
Current Liabilities
Balance Sheet
+78.7%
$727K→$1.3M

Current liabilities surged 78.7% — significant near-term obligations; verify ability to meet short-term debt.

Stockholders Equity
Balance Sheet
-11.5%
-$6.1M→-$6.8M

Equity decreased 11.5% — buybacks or losses reducing book value, monitor solvency ratios.

LANGUAGE CHANGES
NEW — 2026-03-26
PRIOR — 2025-03-27
ADDED
10-K FY false 0002029769 KY CA For the period from June 28, 2024 (inception) through December 31, 2024 excluded 656,250 Class B ordinary shares subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters (Note 5).
On October 30, 2024, the underwriters closed on the partial exercise of the over-allotment option granted to the underwriters of the Initial Public Offering and purchased an additional 1,699,029 Public Units.
The underwriters have forfeited their right to purchase the remaining 925,972 Public Units that they were entitled to purchase under their over-allotment option, consequently 231,492 of Class B ordinary shares were forfeited and cancelled on that date.
III Life Sciences (Exact Name of Registrant as Specified in Its Charter) Cayman Islands 98-1799512 State or other jurisdiction of incorporation or organization I.R.S.
See the definitions of large accelerated filer, accelerated filer, smaller reporting company, and emerging growth company in Rule 12b-2 of the Exchange Act.
+7 more — sign up free →
REMOVED
Please click on the OK button below to proceed to the selected site.
Secure .gov websites use HTTPS A lock ( Lock A locked padlock ) or https:// means you ve safely connected to the .gov website.
Share sensitive information only on official, secure websites.
Founded to help our country respond to the Great Depression, we re the agency that protects investors from misconduct, promotes fairness efficiency in the securities markets, and facilitates capital formation for those looking to hire, innovate, and grow.
About the SEC Quick Links We work together to make a positive impact on America s economy, our capital markets, and people s lives.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →